Mission:Cure Blog
The Mission: Cure Blog is written by our team, medical experts, and members of our community in an effort to bring the latest developments and resources to patients and share the pancreatitis experience.
No results match those filters yet.
Pancreatitis at 19: “Even When I Looked Fine, I Was Struggling Inside”
Diagnosed just before her 20th birthday, this patient opens up about years of hospitalization, feeling unseen, and what she’d tell someone newly diagnosed with pancreatitis.
Autoimmune Pancreatitis Webinar Q&A
At a recent Mission: Cure patient education webinar, Dr. Yasmin Hernandez-Barco of Massachusetts General Hospital and Harvard Medical School, joined by Katharine Provencher of the
Pediatric EPI: Causes, Symptoms & Diagnosis in Children (Part 1)
In this Mission: Cure video, Dr. Freeman answers common questions about pediatric exocrine pancreatic insufficiency (EPI), including causes, symptoms & diagnosis
Step-By-Step Guide for Finding High Quality Supplements
Dr. Roberts walks you through how to pick the right supplements, especially for pancreatitis, digestive issues, or nutrient deficiencies.
Now Hiring: Operations and People Manager
Operations and People Manager Your career at Mission: Cure can help improve the lives of people who are suffering and change the way diseases are
Mission: Cure Announces Partnership With Cibus Therapeutics and Greenstone Biosciences to Advance a New Anti-Inflammatory Treatment for Chronic Pancreatitis
December 2025 — Mission: Cure is pleased to announce a collaboration with Cibus Therapeutics and Greenstone Biosciences, two biotechnology companies working together developing next-generation treatments
A Community for People Navigating High Triglycerides
High triglyceride levels can affect people in different ways. High triglycerides often don’t cause symptoms, so many people don’t realize their levels are elevated until
FDA Approves New Treatment for Familial Chylomicronemia Syndrome (FCS)
We have some exciting news for people living with pancreatitis caused by the FCS genetic mutation. On November 18, 2025, the FDA has approved REDEMPLO®
Remembering Sam Shrauger
With heavy hearts, Mission: Cure shares the news of the passing of a visionary leader, dedicated advisor, and generous supporter, Sam Shrauger.